Sign in

You're signed outSign in or to get full access.

Carol Lindstrom

Director at EXPONENTEXPONENT
Board

About Carol Lindstrom

Carol Lindstrom (age 71) has served as an independent director of Exponent, Inc. since 2017. She is the former Vice Chairman of Deloitte LLP and President of the Deloitte Foundation, with eight years on the Deloitte & Touche Tohmatsu Global Board; earlier, she was a partner at Andersen Consulting. At Exponent, she chairs the Nominating and Governance Committee and serves on the Audit and Human Resources Committees, bringing deep professional services leadership and governance expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
Deloitte LLPVice Chairman; led strategic relationship managementNot disclosedSenior leadership across client and practice management
Deloitte FoundationPresidentNot disclosedOversight of philanthropic initiatives
Deloitte & Touche TohmatsuGlobal Board Member8 yearsGlobal governance experience
Andersen ConsultingPartnerNot disclosedConsulting leadership

External Roles

OrganizationTickerRoleCommittees
Genpact LimitedGDirectorNot disclosed in EXPO proxy
ASGN IncorporatedASGNDirectorNot disclosed in EXPO proxy

Board Governance

  • Independence: Board determined Lindstrom is independent under Nasdaq listing standards .
  • Board & Committees: 8 Board meetings in fiscal 2024; all directors attended at least 75% of applicable Board/committee meetings .
  • Committee assignments:
    • Audit Committee member (Audit Committee held 8 meetings in fiscal 2024; financial experts designated are Brown and Richardson) .
    • Human Resources Committee member (5 meetings in fiscal 2024) .
    • Nominating & Governance Committee Chair (4 meetings in fiscal 2024) .
  • Board leadership: CEO and Chair roles are separated; Lead Independent Director is Karen A. Richardson .
CommitteeRoleMeetings in FY2024
AuditMember8
Human ResourcesMember5
Nominating & GovernanceChair4

Fixed Compensation

  • Structure (Non-Employee Directors):
    • Annual cash retainer: $80,000 .
    • Committee membership fees: Audit Committee $12,000 .
    • Chair fees: Nominating & Governance Committee Chair $15,000 .
    • Annual RSU grant: $145,000 grant-date fair value; cliff vests the day prior to the next annual meeting following grant .
  • FY2024 Compensation (actual):
    • Cash fees: $107,000 (retainer + audit membership + nom/gov chair) .
    • Stock awards: $145,089 grant-date fair value .
    • Total: $252,089 .
ComponentFY2024 Amount
Cash fees (retainer + committees)$107,000
RSU grant (fair value)$145,089
Total$252,089
Cash Fee BreakdownAmount
Annual cash retainer$80,000
Audit Committee member$12,000
Nominating & Governance Chair$15,000
Total cash fees$107,000
Equity Grant Details (FY2024)Value / UnitsVesting
RSUs granted June 6, 20241,525 units; $145,000 fair valueCliff vest day prior to 2025 annual meeting (June 5, 2025)

Performance Compensation

  • Directors receive time-based RSUs; no performance-vesting metrics are disclosed for director compensation .
Performance MetricTargetWeightOutcome
None disclosed for director awards

Other Directorships & Interlocks

  • Current public company boards: Genpact Limited (NYSE: G), ASGN Incorporated (NYSE: ASGN) .
  • Compensation committee interlocks: None; HR Committee members (including Lindstrom) were independent; no executive officer directorships creating interlocks were reported .

Expertise & Qualifications

  • Professional services leadership, strategic relationships, and governance from senior roles at Deloitte and Andersen Consulting .
  • Committee leadership experience as Chair of Nominating & Governance; service on Audit and HR Committees .
  • Independent director status; experience aligns with Exponent’s professional services domain .

Equity Ownership

  • Beneficial ownership: 7,396 shares as of April 9, 2025; less than 1% of outstanding shares .
  • RSUs within 60 days: Includes 1,525 shares to be issued upon conversion of RSUs within 60 days of April 9, 2025 (aligned with annual director grant vesting) .
  • Unvested RSUs outstanding as of January 3, 2025: 1,525 .
  • Ownership guidelines: Directors must hold 3× annual cash retainer; all non-employee directors met or are on track within five years; until achieved, must retain at least 50% of net shares delivered; RSUs count toward compliance .
  • Hedging/pledging: Prohibited for directors .
ItemAmount / Status
Beneficial ownership (shares)7,396; <1%
RSUs convertible within 60 days of 4/9/20251,525
Unvested RSUs at 1/3/20251,525
Director ownership guideline3× annual cash retainer; compliant/on track
Hedging/pledgingProhibited

Governance Assessment

  • Committee effectiveness: As Nominating & Governance Chair, Lindstrom oversees board evaluations, director compensation for non-employee directors, and governance/social responsibility—core to board quality and effectiveness .
  • Financial oversight: Audit Committee membership adds financial reporting and compliance oversight; although audit committee financial expert designation applies to Brown and Richardson, Lindstrom contributes to oversight and independence .
  • Independence & conflicts: Board affirmatively determined independence; no related-party transactions disclosed for Lindstrom; HR Committee interlocks absent—reduces conflict risk .
  • Attendance & engagement: Board held 8 meetings; directors met at least the 75% attendance threshold; multi-committee service indicates engagement .
  • Alignment: Director equity grants and ownership guidelines enforce skin-in-the-game; hedging/pledging prohibited—positive alignment signal .
  • RED FLAGS: None identified—no related-party exposure, no Section 16 delinquency cited for Lindstrom, no hedging/pledging, and robust governance processes in place .
  • Shareholder sentiment: Prior say-on-pay support ~92.8% for FY2023 indicates broad investor alignment with compensation governance, indirectly supportive of board oversight quality .